Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Sharma

Showing results (451-460 of 464) with videos related to

Pageof 47
Sort By:
South Asian Journal of Cancer|February 16, 2019
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis studyAnant Ramaswamy, Vikas Ostwal, Nikhil Pande, et al.
South Asian Journal of Cancer|March 10, 2025
Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is MorePrasad Narayanan, Shyam Aggarwal, Manish Singhal, et al.
The Indian Journal of Medical Research|November 9, 2022
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from IndiaAkash Kumar, Saphalta Baghmar, Prashant Mehta, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
South Asian Journal of Cancer|March 24, 2025
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)Purvish M Parikh, Ghanashyam Biswas, Nilesh Ashok Dhamne, et al.
Circulation|March 28, 2026
Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and MenHarmony R Reynolds, Akiko Maehara, Bobby Heydari, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
The Journal of Infectious Diseases|March 3, 2022
Cost of Illness Due to Severe Enteric Fever in IndiaDilesh Kumar, Atul Sharma, Saroj Kumar Rana, et al.
JCO Global Oncology|November 14, 2024
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III TrialKumar Prabhash, Chetan Deshmukh, Hemant Malhotra, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2025
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trialJohn W K Chia, Eva Segelov, Yanhong Deng, et al.
Pageof 47

Showing results (451-460 of 464) with videos related to

Sort By:
Pageof 47
South Asian Journal of Cancer|February 16, 2019
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis studyAnant Ramaswamy, Vikas Ostwal, Nikhil Pande, et al.
South Asian Journal of Cancer|March 10, 2025
Adjuvant Chemotherapy in Colon Cancer: Simple is Better… Less is MorePrasad Narayanan, Shyam Aggarwal, Manish Singhal, et al.
The Indian Journal of Medical Research|November 9, 2022
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from IndiaAkash Kumar, Saphalta Baghmar, Prashant Mehta, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
South Asian Journal of Cancer|March 24, 2025
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)Purvish M Parikh, Ghanashyam Biswas, Nilesh Ashok Dhamne, et al.
Circulation|March 28, 2026
Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and MenHarmony R Reynolds, Akiko Maehara, Bobby Heydari, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
The Journal of Infectious Diseases|March 3, 2022
Cost of Illness Due to Severe Enteric Fever in IndiaDilesh Kumar, Atul Sharma, Saroj Kumar Rana, et al.
JCO Global Oncology|November 14, 2024
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III TrialKumar Prabhash, Chetan Deshmukh, Hemant Malhotra, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2025
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trialJohn W K Chia, Eva Segelov, Yanhong Deng, et al.
Pageof 47